Dynamk Capital is a growth equity and venture capital firm investing in life science companies. Dynamk's investment strategy is centered on Life Science Industrials: companies developing technologies, tools, and services that enable the full biopharma continuum across discovery, development, and manufacturing of therapeutics. Dynamk is headquartered in New York City.